Efficacy and safety of Kanglaite injection combined with chemotherapy for colorectal cancer

Abstract

Background: The incidence and mortality of colorectal cancer are high. Chemotherapy is currently the commonly used therapeutic scheme, but there are drug resistance and toxic and side effects. Kanglaite (KLT) injection is a broad-spectrum anticancer drug extracted from Semen Coicis (Yi Yi Ren) , which has been widely used in the treatment of colorectal cancer. Clinical practice shows that KLT injection combined with chemotherapy has certain therapeutic advantages, but there is a lacking of evidence of evidence-based medicine. The purpose of this study is to systematically investigate the efficacy and safety of KLT injection combined with chemotherapy in the treatment of colorectal cancer. Methods: Randomized controlled trials of KLT injection combined with chemotherapy in the treatment of colorectal cancer were retrieved from English databases (PubMed, Embase, Web of Science, the Cochrane Library) and Chinese databases (China National Knowledge Infrastructure, Wanfang, Chongqing VIP Chinese Science and Technology Periodical Database, Chinese Biological and Medical database), as well as searching Baidu academic and Google academic manually, and the retrieval time was from their establishment to August 2020. Two researchers independently conducted data extraction and literature quality evaluation on the quality of the included literatures, and meta-analysis was conducted on the included literatures using RevMan 5.3 (developed by the UK's International Cochrane Collaboration). Results: This study assessed the efficacy and safety of KLT injection combined with chemotherapy in the treatment of colorectal cancer by effective rate, Karnofsky Performance Status, Carcinoemybryonic Angtigen remission rate, pain remission rate, and incidence of adverse reactions etc. Conclusions: This study will provide reliable evidence-based evidence for the clinical application of KLT injection combined with chemotherapy in the treatment of colorectal cancer. Ethics and dissemination: The private information from individuals will not be published. This systematic review also will not involve endangering participant rights. Ethical approval is not required. The results may be published in a peer-reviewed journal or disseminated in relevant conferences. OSF Registration number: DOI 10.17605/OSF.IO/EKVAF

Kanglaite Combined With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy for Stage III/IV Non-Small Cell Lung Cancer: A PRISMA-Compliant Meta-Analysis

“…Clinically, KLT has synergistic effects with radiotherapy and chemotherapy, it has been used in the adjuvant treatment of various tumors such as lung cancer ( Hailang et al, 2020a ; Li et al, 2020 ), breast Cancer ( Liu S. et al, 2021 ), hepatocellular carcinoma ( Liu et al, 2019 ; Dou et al, 2020 )and colorectal cancer ( Mao et al, 2020 ). The main effects targeted the improvements of clinical efficacy, performance status, KPS score, immune function and the reduction of the side effects of radiotherapy and chemotherapy.…”

Combination of thalidomide and Clostridium butyricum relieves chemotherapy-induced nausea and vomiting via gut microbiota and vagus nerve activity modulation

“…Colorectal cancer (CRC) is a cancer occurring in the colon or rectum, with over 1.9 million new cases and 935,000 deaths estimated in 2020, ranking the third in incidence and the second in mortality (1,2). For patients' treatment, systemic chemotherapy is the mainstay treatment besides surgery and local radiotherapy and has been wildly used in advanced CRC (3).…”

Network Pharmacology-Based Analysis of the Potential Biological Mechanisms of Coix Seed against Colorectal Cancer

“…Coix seed is commonly used in combination with chemotherapy drugs for CRC treatment. Multiple randomized controlled trials indicate that the combination therapy has a higher therapeutic effect and less side effects compared with use of chemotherapy alone [ 12 ]. Several studies in modern medicine have shown that the occurrence and development of CRC are associated with the immune status.…”